Registered Malawi · PMRA

CHYMORAL FORTE 100 000 ARMOUR UNITS TABLET

TRYPSIN-CHYMOTRYPSIN

PMPB/PL414/3 TABLET

What it does

Trypsin-chymotrypsin are digestive enzymes that help break down proteins in the body.

Commonly used for: digestive issues (malabsorption), pancreatitis, certain gastrointestinal disorders

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
PMPB/PL414/3
Registration date
18/01/2013
Expiry date
30/06/2013
Status
Registered
Active ingredient
TRYPSIN-CHYMOTRYPSIN
Dosage form
TABLET
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
-
Applicant / LTR
-
Country of origin
-

Source: Pharmacy and Medicines Regulatory Authority · fetched 2026-04-21 17:37:42 · updated 2026-09-22 04:33:03

Disclaimer: This information is sourced from Pharmacy and Medicines Regulatory Authority (Malawi). Always consult a qualified healthcare professional before using any medication.

About this medicine

Trypsin-chymotrypsin are digestive enzymes that help break down proteins in the body.

What it treats

  • digestive issues (malabsorption)
  • pancreatitis
  • certain gastrointestinal disorders

How it works

These enzymes help the body digest and absorb nutrients from food by breaking down proteins into smaller pieces.

Who it's for

This medication is for people who have trouble digesting food due to a lack of digestive enzymes.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: trypsinchymotrypsin

Trypsin and chymotrypsin are proteolytic enzymes that play a critical role in the digestion of proteins in the small intestine. They are derived from the pancreas and are secreted in their inactive forms (trypsinogen and chymotrypsinogen) before being activated in the intestinal lumen. These enzymes hydrolyze peptide bonds in proteins, facilitating their breakdown into smaller peptides and amino acids, which can then be absorbed by the body. Trypsin specifically cleaves on the carboxyl side of lysine and arginine residues, while chymotrypsin preferentially targets aromatic amino acids such as phenylalanine, tryptophan, and tyrosine.

Indications

  • Pancreatic insufficiency
  • Digestive disorders
  • Protein malabsorption syndromes
  • Post-surgical digestive support

Dosage

Adults: Refer to specific guidelines for dosing, as it can vary based on clinical condition

Mechanism of action

Trypsin and chymotrypsin exert their effects by cleaving peptide bonds in proteins. The activation of trypsinogen to trypsin occurs through the action of enteropeptidase, which is released from the intestinal mucosa. Activated trypsin then activates chymotrypsinogen to chymotrypsin, creating a cascade of proteolytic activity. This enzymatic action results in the breakdown of dietary proteins into smaller peptides and amino acids for absorption, facilitating nutrient utilization.

Pharmacodynamics

The pharmacodynamics of trypsin and chymotrypsin involve the modulation of protein digestion and absorption. By hydrolyzing peptide bonds, these enzymes enhance the digestion of dietary proteins, leading to improved nutrient availability. The efficiency of protein digestion is crucial for overall metabolic health, particularly in cases of pancreatic insufficiency or conditions where protein absorption may be impaired.

Pharmacokinetics

The pharmacokinetics of trypsin and chymotrypsin are characterized by their local action in the gastrointestinal tract. Once secreted into the small intestine, they act immediately on dietary proteins. They do not have systemic absorption in healthy individuals, as they are intended to function within the gastrointestinal lumen. The half-life of these enzymes is relatively short due to their rapid action and subsequent degradation by other proteolytic enzymes present in the intestinal environment.

Pregnancy

There are no well-controlled studies in pregnant women. Use only if clearly needed and the potential benefits justify the potential risks to the fetus.

Breast-feeding

It is not known whether trypsin-chymotrypsin is excreted in human milk. Caution should be exercised when administering to nursing mothers.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.